Inclusion of Ethical Issues in Dementia Guidelines: A Thematic Text Analysis
Background:
Clinical practice guidelines (CPGs) aim to improve professionalism in health care. However, current CPG development manuals fail to address how to include ethical issues in a systematic and transparent manner. The objective of this study was to assess the representation of ethical issues in general CPGs on dementia care.
Methods and Findings:
To identify national CPGs on dementia care, five databases of guidelines were searched and national psychiatric associations were contacted in August 2011 and in June 2013. A framework for the assessment of the identified CPGs' ethical content was developed on the basis of a prior systematic review of ethical issues in dementia care. Thematic text analysis and a 4-point rating score were employed to assess how ethical issues were addressed in the identified CPGs. Twelve national CPGs were included. Thirty-one ethical issues in dementia care were identified by the prior systematic review. The proportion of these 31 ethical issues that were explicitly addressed by each CPG ranged from 22% to 77%, with a median of 49.5%. National guidelines differed substantially with respect to (a) which ethical issues were represented, (b) whether ethical recommendations were included, (c) whether justifications or citations were provided to support recommendations, and (d) to what extent the ethical issues were explained.
Conclusions:
Ethical issues were inconsistently addressed in national dementia guidelines, with some guidelines including most and some including few ethical issues. Guidelines should address ethical issues and how to deal with them to help the medical profession understand how to approach care of patients with dementia, and for patients, their relatives, and the general public, all of whom might seek information and advice in national guidelines. There is a need for further research to specify how detailed ethical issues and their respective recommendations can and should be addressed in dementia guidelines.
Please see later in the article for the Editors' Summary
Vyšlo v časopise:
Inclusion of Ethical Issues in Dementia Guidelines: A Thematic Text Analysis. PLoS Med 10(8): e32767. doi:10.1371/journal.pmed.1001498
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001498
Souhrn
Background:
Clinical practice guidelines (CPGs) aim to improve professionalism in health care. However, current CPG development manuals fail to address how to include ethical issues in a systematic and transparent manner. The objective of this study was to assess the representation of ethical issues in general CPGs on dementia care.
Methods and Findings:
To identify national CPGs on dementia care, five databases of guidelines were searched and national psychiatric associations were contacted in August 2011 and in June 2013. A framework for the assessment of the identified CPGs' ethical content was developed on the basis of a prior systematic review of ethical issues in dementia care. Thematic text analysis and a 4-point rating score were employed to assess how ethical issues were addressed in the identified CPGs. Twelve national CPGs were included. Thirty-one ethical issues in dementia care were identified by the prior systematic review. The proportion of these 31 ethical issues that were explicitly addressed by each CPG ranged from 22% to 77%, with a median of 49.5%. National guidelines differed substantially with respect to (a) which ethical issues were represented, (b) whether ethical recommendations were included, (c) whether justifications or citations were provided to support recommendations, and (d) to what extent the ethical issues were explained.
Conclusions:
Ethical issues were inconsistently addressed in national dementia guidelines, with some guidelines including most and some including few ethical issues. Guidelines should address ethical issues and how to deal with them to help the medical profession understand how to approach care of patients with dementia, and for patients, their relatives, and the general public, all of whom might seek information and advice in national guidelines. There is a need for further research to specify how detailed ethical issues and their respective recommendations can and should be addressed in dementia guidelines.
Please see later in the article for the Editors' Summary
Zdroje
1. IOM (2011) Clinical practice guidelines we can trust. Washington (D.C.): National Academies Press, Institute of Medicine (IOM).
2. HardingE, PettinariCJ, BrownD, HaywardM, TaylorC (2011) Service user involvement in clinical guideline development and implementation: learning from mental health service users in the UK. Int Rev Psychiatr 23: 352–357.
3. GuyattGH, OxmanAD, VistGE, KunzR, Falck-YtterY, et al. (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336: 924–926.
4. GuyattG, AklEA, HirshJ, KearonC, CrowtherM, et al. (2010) The vexing problem of guidelines and conflict of interest: a potential solution. Ann Intern Med 152: 738–741.
5. NICE (2009) The guidelines manual. London: National Institute for Health and Clinical Excellence (NICE), Available: www.nice.org.uk.
6. WHO (2008) WHO Handbook for guideline development. Geneva: World Health Organization (WHO).
7. SIGN (2008) SIGN 50. A guideline developer's handbook. Edinburgh: Scottish Intercollegiate Guidelines Network.
8. CMA (2007) Handbook on clinical practice guidelines. Ottawa: Canadian Medical Association.
9. ABIM Foundation, ACP–ASIM Foundation, European Federation of Internal Medicine (2002) Medical professionalism in the new millennium: a physicians' charter. Lancet 359: 520–522.
10. Beauchamp TL, Childress JF (2008) Principles of Biomedical Ethics. New York: Oxford University Press.
11. American Psychiatric Association (2010) The Principles of medical ethics: with annotations especially applicable to psychiatry. Washington (D.C.): American Psychiatric Association.
12. HughesJC, HopeT, ReaderS, RiceD (2002) Dementia and ethics: the views of informal carers. J Roy Soc Med 95: 242–246.
13. GiacominiM, CookD, DeJeanD, ShawR, GedgeE (2006) Decision tools for life support: a review and policy analysis. Crit Care Med 34: 864–870.
14. LemiengreJ, de CasterleBD, Van CraenK, SchotsmansP, GastmansC (2007) Institutional ethics policies on medical end-of-life decisions: a literature review. Health Policy 83: 131–143.
15. StrechD, SchildmannJ (2011) Quality of ethical guidelines and ethical content in clinical guidelines: the example of end-of-life decision-making. J Med Ethics 37: 390–396.
16. Nuffield Council on Bioethics (2009) Dementia: ethical issues. London: Nuffield Council on Bioethics.
17. Hughes JC, Baldwin C (2008) Ethics and the old age psychiatry. Jacoby R, Oppenheimer C, Dening T, editors. Oxford textbook of old age psychiatry. New York: Oxford University Press. pp. 709–729.
18. Oppenheimer C (2009) Ethics in old age psychiatry. Bloch S, Green S, editors. Psychiatric ethics. New York: Oxford University Press. pp. 409–433.
19. StrechD, MertzM, KnuppelH, NeitzkeG, SchmidhuberM (2013) The full spectrum of ethical issues in dementia care: systematic qualitative review. Brit J Psychiatr 202: 400–406.
20. Dixon-WoodsM, AgarwalS, JonesD, YoungB, SuttonA (2005) Synthesising qualitative and quantitative evidence: a review of possible methods. J Health Serv Res Policy 10: 45–53.
21. ErikssonS, HoglundAT, HelgessonG (2008) Do ethical guidelines give guidance? A critical examination of eight ethics regulations. Camb Q Healthc Ethics 17: 15–29.
22. BrouwersMC, KhoME, BrowmanGP, BurgersJS, CluzeauF, et al. (2010) AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ 182: E839–842.
23. Royal Australian College of General Practitioners (2003) Care of patients with dementia in general practice: guidelines. Sydney: Royal Australian College of General Practitioners, NSW Dept. of Health.
24. Dorner T, Rieder A, Stein KV (2011) Besser Leben mit Demenz - Medizinische Leitlinie für die integrierte Versorgung Demenzerkrankter. Wien: Competence Center Integrierte Versorgung.
25. CCCDTD3 (2007) 3rd Canadian Consensus Conference on Diagnosis and Treatment of Dementia. Montreal: 3rd CCCDTD
26. National Institute for Health and Clinical Excellence, National Collaborating Centre for Mental Health (2006) Dementia: the NICE-Scie guideline on supporting people with dementia and their carers in health and social care. London: National Institute for Health and Clinical Excellence (NICE). 978-1-85433-451-0 978-1-85433-451-0.
27. National Institute for Health and Clinical Excellence (2010) End of life care for people with dementia. Commissioning guide - implementing NICE guidance. London: National Institute for Health and Clinical Excellence (NICE).
28. Haute Autorité de Santé (2008) Diagnosis and treatment of Alzheimer's disease and related conditions. Saint-Denis La Plaine: Haute Autorité de Santé (HAS), Professional Guidelines Department.
29. DGN, DGPPN (2009) S3-Leitlinie “Demenzen”. Bonn: Deutsche Gesellschaft für Psychiatrie Psychotherapie und Nervenheilkunde (DGPPN), Deutsche Gesellschaft für Neurologie (DGN).
30. Ministry of Health Malaysia (2009) Management of dementia. Putrajaya: Ministry of Health Malaysia, CPG Secretariat, Health Technology Assessement Section, Guideline Development Group (Chair: Suraya Yusoff).
31. Ministry of Health New Zealand (1997) Guidelines for the support and management of people with dementia. Ministry of Health New Zealand.
32. Scottish Intercollegiate Guidelines Network (2006) Management of patients with dementia - a national clinical guideline. Edinburgh: Scottish Intercollegiate Guidelines Network, Guideline Development Group (Chair: Peter Connelly).
33. Ministry of Health Singapore (2007) Clinical practice guideline: dementia. Singapore: Ministry of Health, Singapore. 978-981-05-8095-7 978-981-05-8095-7.
34. Expertengruppe der Schweiz (2008) Konsensus zur Diagnostik und Betreuung von Demenzkranken in der Schweiz. Muttenz: Alzheimer Forum Schweiz, Schweiz Med Forum.
35. American Psychiatric Association (2007) Practice guideline for the treatment of patients with Alzheimer's disease and other dementias. Arlington (VA): American Psychiatric Association (APA), Work Group on Alzheimer's Disease and Other Dementias (Chair: Peter V. Rabins).
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2013 Číslo 8
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- DESATORO PRE PRAX: Aktuálne odporúčanie ESPEN pre nutričný manažment u pacientov s COVID-19
- Metamizol v liečbe pooperačnej bolesti u detí do 6 rokov veku
- Co dělat při intoleranci statinů?
Najčítanejšie v tomto čísle
- Switching HIV Treatment in Adults Based on CD4 Count Versus Viral Load Monitoring: A Randomized, Non-Inferiority Trial in Thailand
- Risk of Early-Onset Neonatal Infection with Maternal Infection or Colonization: A Global Systematic Review and Meta-Analysis
- Inclusion of Ethical Issues in Dementia Guidelines: A Thematic Text Analysis
- Country Contextualization of the Mental Health Gap Action Programme Intervention Guide: A Case Study from Nigeria